O admirável Projeto Genoma Humano
暂无分享,去创建一个
[1] E. Parens,et al. Disability rights critique of prenatal genetic testing: reflections and recommendations. , 1999, Mental retardation and developmental disabilities research reviews.
[2] M. Cassier,et al. Recherche, médecine et marché : la génétique du cancer du sein , 2000 .
[3] Linda F. Hogle. Réglementer les innovations utilisant des tissus humains : hybrides et gouvernance , 2000 .
[4] M. Cassier,et al. Le génome : bien privé ou bien commun ? , 2000 .
[5] H. Greely,et al. Iceland's plan for genomics research: facts and implications. , 2000, Jurimetrics.
[6] N. Holtzman,et al. Will genetics revolutionize medicine? , 2000, The New England journal of medicine.
[7] J. Schenker,et al. BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management. , 2000, Obstetrical & gynecological survey.
[8] John Harris,et al. Is there a coherent social conception of disability? , 2000, Journal of medical ethics.
[9] M. Cassier. Relations entre secteurs public et privé dans la recherche sur le génome. , 2000 .
[10] E. Parens,et al. The disability rights critique of prenatal genetic testing. Reflections and Recommendations. , 1999, The Hastings Center report.
[11] M. Bonduelle,et al. Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] G. Mcgee. Gene Patents Can Be Ethical , 1998, Cambridge Quarterly of Healthcare Ethics.
[13] M. Cho,et al. Disease Genes Are Not Patentable: A Rebuttal of McGee , 1998, Cambridge Quarterly of Healthcare Ethics.
[14] M. Burgess,et al. Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era , 1998 .
[15] P. Miller. Genetic Discrimination in the Workplace , 1998, Journal of Law, Medicine & Ethics.
[16] T. Raffin,et al. Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society. Breast Cancer Working Group. , 1998, Journal of women's health.
[17] E. Juengst. Groups as Gatekeepers to Genomic Research: Conceptually Confusing, Morally Hazardous, and Practically Useless , 1998, Kennedy Institute of Ethics journal.
[18] E. Parens. Is better always good? The Enhancement Project. , 1998, The Hastings center report.
[19] M. Hanson. Religious voices in biotechnology: the case of gene patenting. , 1997, The Hastings Center report.
[20] Marilena Correa. As novas tecnologias reprodutivas: uma revolução a ser assimilada , 1997 .
[21] N. Holtzman,et al. "Decoding" informed consent. Insights from women regarding breast cancer susceptibility testing. , 1997, The Hastings Center report.
[22] K. Rothenberg. Breast cancer, the genetic "quick fix," and the Jewish community. Ethical, legal, and social challenges. , 1997, Health matrix.
[23] P. Bourret,et al. Vers une colonisation génétique de la médecine , 1996 .
[24] S. Levay,et al. Evidence for a biological influence in male homosexuality. , 1994, Scientific American.
[25] P. Reilly. Gene mapping: Using law and ethics as guides. , 1993 .
[26] L. Walters. The ethics of human gene therapy , 1986, Nature.